Skip to main content

Advertisement

HER2 upregulates fatty acid synthase and acetyl-CoA carboxylase at a translational level in breast cancer cells

Article metrics

  • 1336 Accesses

Overexpression of the HER2 oncogene is observed in approximately 30% of human breast carcinoma specimens. HER2-overexpressing breast cancer cells, such as SK-BR-3 and BT-474 cells, express fatty acid synthase (FAS) at a higher level than MCF-7 cells or MDA-MB-231 cells, where HER2 is expressed at a moderate or low level. Adenovirus-mediated HER2 expression in MDA-MB-231 cells increased acetyl-CoA carboxylase alpha (ACCα) and FAS protein levels without significant increases of their mRNA. HER2-mediated increases of ACCα and FAS proteins were inhibited by the PI3K inhibitor, LY294002, and the mTOR inhibitor, rapamycin. But sterol regulatory element-binding protein 1 (SREBP1) and ATP citrate lyase (ACL) mRNA and protein levels were not changed by HER2 overexpression, LY294002 or rapamycin. In conclusion, our results suggest that HER2-overexpressing cells lead to increased ACCα and FAS proteins at a translational level via the activation of the mTOR signaling pathway and not through SREBP-1c-mediated transcriptional activation.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yoon, S., Lee, M., Park, B. et al. HER2 upregulates fatty acid synthase and acetyl-CoA carboxylase at a translational level in breast cancer cells. Breast Cancer Res 7, P4.02 (2005) doi:10.1186/bcr1132

Download citation

Keywords

  • Rapamycin
  • mTOR Signaling
  • Human Breast Carcinoma
  • HER2 Overexpression
  • mTOR Signaling Pathway